Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 2/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.52 |
| ▸ | DHFR | P00374 | 1/20 | 0.51 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.44 |
| ▸ | SOAT1 | P35610 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15068306 | 1.00 | GCGR (0.53) | GCGRGPR84DHFRHSD11B1SOAT1 | |
| SCHEMBL19281428 | 0.94 | GCGR (0.49) | GCGRGPR84DHFRHSD11B1SOAT1 | |
| SCHEMBL15068307 | 0.76 | GPR84 (0.63) | GCGRGPR84DHFRHSD11B1SOAT1 | |
| SCHEMBL15068264 | 0.76 | GPR84 (0.63) | GCGRGPR84DHFRHSD11B1SOAT1 | |
| SCHEMBL28111153 | 0.76 | GCGR (0.58) | GCGRGPR84DHFRHSD11B1 | |
| SCHEMBL6512533 | 0.76 | GCGR (0.54) | GCGRGPR84DHFRHSD11B1 | |
| SCHEMBL8516372 | 0.75 | DHFR (0.52) | GCGRGPR84DHFRHSD11B1SOAT1 | |
| SCHEMBL28160159 | 0.73 | TACR3 (0.54) | GCGRGPR84DHFR | |
| SCHEMBL1754697 | 0.72 | DHFR (0.46) | GCGRGPR84DHFRHSD11B1SOAT1 | |
| Ammonia Solution, Strong SCHEMBL17728155 | 0.71 | MAPK14 (0.44) | GCGRDHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130172457-A1 | Phosphorus-Containing Mixtures, Processes for Preparing Them and Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2013-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172457-A1 | Phosphorus-Containing Mixtures, Processes for Preparing Them and Use Thereof | C9, PHOSPHO1, C5 | GCGR 3235/4885GPR84 3173/4885DHFR 3169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.